+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ophthalmic Suspensions"

Conjunctivitis Treatment Market Report 2025 - Product Thumbnail Image

Conjunctivitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Tobramycin Eye Drop Global Market Report 2024 - Product Thumbnail Image

Tobramycin Eye Drop Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Optic Nerve Disorders Treatment Market Report 2025 - Product Thumbnail Image

Optic Nerve Disorders Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Glaucoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Glaucoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 360 Pages
  • Global
From
From
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator

Ophthalmic Suspensions are a type of eye drop used to treat a variety of eye conditions. These suspensions are typically composed of a combination of active ingredients, such as antibiotics, steroids, and anti-inflammatory agents, suspended in a liquid vehicle. Ophthalmic Suspensions are used to treat a variety of conditions, including conjunctivitis, blepharitis, and dry eye. They are also used to treat glaucoma, cataracts, and other eye diseases. The Ophthalmic Suspensions market is a rapidly growing segment of the Optical industry. This market is driven by the increasing prevalence of eye diseases, the growing demand for effective treatments, and the development of new technologies. The market is also driven by the increasing availability of generic and over-the-counter products. Some of the major companies in the Ophthalmic Suspensions market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more